Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies.
Hans-Christoph DienerPeter McAllisterTim P JürgensYoel KesslerXiaoping NingJoshua M CohenVerena Ramirez CamposSteve BarashStephen D SilbersteinPublished in: Cephalalgia : an international journal of headache (2022)
NCT02629861 (HALO EM, https://clinicaltrials.gov/ct2/show/NCT02629861), NCT02621931 (HALO CM, https://clinicaltrials.gov/ct2/show/NCT02621931), NCT03308968 (FOCUS, https://clinicaltrials.gov/ct2/ show/NCT03308968).